Adam Petrich: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Primary cardiac lymphoma : An analysis of presentation, treatment, and outcome patterns

Adam Petrich, Soung Ick Cho, Henny Billett

Journal:

Year:

2011

Language:

english

File:

PDF, 233 KB

english, 2011

2

Emerging Therapeutic Targets in Diffuse Large B-Cell Lymphoma

Murali Janakiram, Venu K. Thirukonda, Matthew Sullivan, Adam M. Petrich

Journal:

Current Treatment Options in Oncology

Year:

2012

Language:

english

File:

PDF, 547 KB

english, 2012

3

F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma

Gentzler, Ryan D., Evens, Andrew M., Rademaker, Alfred W., Weitner, Bing B., Mittal, Bharat B., Dillehay, Gary L., Petrich, Adam M., Altman, Jessica K., Frankfurt, Olga, Variakojis, Daina, Singhal, Se

Journal:

British Journal of Haematology

Year:

2014

Language:

english

File:

PDF, 287 KB

english, 2014

4

MYC-associated and double-hit lymphomas: A review of pathobiology, prognosis, and therapeutic approaches

Petrich, Adam M., Nabhan, Chadi, Smith, Sonali M.

Journal:

Year:

2014

Language:

english

File:

PDF, 298 KB

english, 2014

5

Phase II study of alemtuzumab–rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes

Frankfurt, Olga, Ma, Shuo, Gordon, Leo, Winter, Jane N., Horowitz, Jeanne M., Rademaker, Alfred, Weitner, Bing Bing, Peterson, LoAnn C., Altman, Jessica K., Tallman, Martin S., Petrich, Adam, Rosen, S

Journal:

Leukemia and Lymphoma

Year:

2015

Language:

english

File:

PDF, 352 KB

english, 2015

6

Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999–2008 and treated with curative intent in the AIDS Malignancy Consortium

Bayraktar, Ulas D., Ramos, Juan Carlos, Petrich, Adam, Gupta, Neel, Lensing, Shelly, Moore, P. C., Reid, Erin G., Aboulafia, David M., Ratner, Lee, Mitsuyasu, Ronald, Cooley, Timothy, Henry, David H.,

Journal:

Leukemia and Lymphoma

Year:

2012

Language:

english

File:

PDF, 235 KB

english, 2012

7

Treatment of Diffuse Large B-cell Lymphoma

Thirukonda, Venu K., Petrich, Adam M.

Journal:

Pathology Case Reviews

Year:

2012

Language:

english

File:

PDF, 302 KB

english, 2012

8

Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma

Petrich, Adam M., Sparano, Joseph A., Parekh, Samir

Journal:

Advances in Hematology

Year:

2012

Language:

english

File:

PDF, 109 KB

english, 2012

9

Factors predicting survival in peripheral T-cell lymphoma in the USA: a population-based analysis of 8802 patients in the modern era

Petrich, Adam M., Helenowski, Irene B., Bryan, Locke J., Rozell, Shaina A., Galamaga, Robert, Nabhan, Chadi

Journal:

British Journal of Haematology

Year:

2015

Language:

english

File:

PDF, 522 KB

english, 2015

10

Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome

Petrich, Adam, Kahl, Brad, Bailey, Howard, Kim, Kyungmann, Turman, Nancy, Juckett, Mark

Journal:

Leukemia and Lymphoma

Year:

2008

Language:

english

File:

PDF, 729 KB

english, 2008

11

The evolving role of lenalidomide in non-Hodgkin lymphoma

Galanina, Natalie, Petrich, Adam, Nabhan, Chadi

Journal:

Leukemia and Lymphoma

Year:

2016

Language:

english

File:

PDF, 1.08 MB

english, 2016

12

Durable Responses With Maintenance Dose-Sparing Regimens of Romidepsin in Cutaneous T-Cell Lymphoma

Martinez-Escala, M. Estela, Kuzel, Timothy M., Kaplan, Jason B., Petrich, Adam, Nardone, Beatrice, Rosen, Steven T., Guitart, Joan

Journal:

Year:

2016

Language:

english

File:

PDF, 260 KB

english, 2016

13

Use of class I histone deacetylase inhibitor romidepsin in combination regimens

Petrich, Adam, Nabhan, Chadi

Journal:

Leukemia and Lymphoma

Year:

2016

Language:

english

File:

PDF, 1.06 MB

english, 2016

14

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort

Evens, Andrew M., Kanakry, Jennifer A., Sehn, Laurie H., Kritharis, Athena, Feldman, Tatyana, Kroll, Aimee, Gascoyne, Randy D., Abramson, Jeremy S., Petrich, Adam M., Hernandez-Ilizaliturri, Francisco

Journal:

American Journal of Hematology

Year:

2015

Language:

english

File:

PDF, 569 KB

english, 2015

15

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma

Landsburg, Daniel J., Petrich, Adam M., Abramson, Jeremy S., Sohani, Aliyah R., Press, Oliver, Cassaday, Ryan, Chavez, Julio C., Song, Kevin, Zelenetz, Andrew D., Gandhi, Mitul, Shah, Namrata, Fenske,

Journal:

Year:

2016

Language:

english

File:

PDF, 179 KB

english, 2016

16

Use of Tissue Microarray and Automated Quantitative Analysis for Screening and Validation of Potential Biomarkers in Mantle Cell Lymphoma

Yang, David T., Quann, Philip J., Petrich, Adam M., Leith, Catherine P., Young, Ken H., Kahl, Brad S.

Journal:

Applied Immunohistochemistry

Year:

2011

Language:

english

File:

PDF, 392 KB

english, 2011

17

Impact of treatment variability on survival in immuno-competent and immuno-compromised patients with primary central nervous lymphoma

Karmali, Reem, Nabhan, Chadi, Petrich, Adam M., Raizer, Jeffrey, Peace, David, Lukas, Rimas, Gordon, Leo I., Basu, Sanjib, Chukkapalli, Vineela, Venugopal, Parameswaran

Journal:

British Journal of Haematology

Year:

2017

Language:

english

File:

PDF, 221 KB

english, 2017

18

Ibrutinib, a BTK inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity in allergic cancer patients receiving drug

Regan, Jennifer A., Petrich, Adam M., Dispenza, Melanie C., Ma, Shuo, Gordon, Leo I., Bochner, Bruce S.

Journal:

Journal of Allergy and Clinical Immunology

Year:

2017

Language:

english

File:

PDF, 126 KB

english, 2017

19

Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity

Regan, Jennifer A., Cao, Yun, Dispenza, Melanie C., Ma, Shuo, Gordon, Leo I., Petrich, Adam M., Bochner, Bruce S.

Journal:

Journal of Allergy and Clinical Immunology

Year:

2017

Language:

english

File:

PDF, 3.36 MB

english, 2017

20

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL

Galanina, Natalie, Smith, Sonali M., Liao, Chuanhong, Petrich, Adam, Libao, Bernadette, Gartenhaus, Ronald, Westin, Jason R., Cohen, Kenneth S., Knost, James A., Stadler, Walter M., Doyle, Austin, Kar

Journal:

British Journal of Haematology

Year:

2017

Language:

english

File:

PDF, 178 KB

english, 2017

21

Multiple Successful Desensitizations to Brentuximab Vedotin: A Case Report and Literature Review

DeVita, Michael D., Evens, Andrew M., Rosen, Steven T., Greenberger, Paul A., Petrich, Adam M.

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2014

Language:

english

File:

PDF, 225 KB

english, 2014

22

Brentuximab Vedotin in Patients With Relapsed HIV-Related Lymphoma

Gandhi, Mitul, Petrich, Adam

Journal:

Journal of the National Comprehensive Cancer Network

Year:

2014

Language:

english

File:

PDF, 121 KB

english, 2014